Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Emma Rose 2025 Nov 15, 00:00

US Stock Market Outlook: Jitters and Potential Catalysts

Ava Grace 2025 Nov 15, 00:00

Fiscal Firefighting: US & Japan's Unorthodox Inflation Strategy

Sophia Claire 2025 Nov 15, 00:00

Guggenheim Partners Sees Fed Rate Cut in December Amid Economic Slowdown Concerns

Ava Grace 2025 Nov 15, 00:00

US Government Shutdown Aftermath: Rate Cut Concerns and Market Uncertainty

Sophia Claire 2025 Nov 15, 00:00

El-Erian Flags Economic Worries: Low-Income Consumers & Debt Refinancing

Frances Wang 2025 Nov 13, 16:00

Commodity market today: Gold prices are rising, what is XAU/USD prediction?

Frances Wang 2025 Nov 13, 16:00

AI stocks are trending: Qualcomm stock, Nvidia (NVDA), AMD stock

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Latest news

Show more
Emma Rose 2025 Nov 15, 12:40

Aster Clarifies Tokenomics Amid Unlock Schedule Confusion

Liam James 2025 Nov 15, 10:40

Robert Kiyosaki: I'm Not Selling My Bitcoin or Gold Amid Market Turmoil, I'll Buy More

Sophia Claire 2025 Nov 15, 10:10

Wall Street Cautious: Fed Rate Cut Doubts, Data Deluge, and Nvidia Earnings Loom

Sophia Claire 2025 Nov 15, 10:10

Wall Street Cautious Amid Economic Data Deluge, Fed Rate Cut Uncertainty, and Bitcoin's Slide

Emma Rose 2025 Nov 15, 09:30

Crypto Market Updates: SEC, ETFs, Saylor, Binance, ARK

Liam James 2025 Nov 15, 07:40

Curve Finance: Evolution into a DeFi Liquidity Cornerstone and Sustainability

Noah Lee 2025 Nov 15, 07:20

ARK Invest Boosts Crypto Equity Holdings: BitMine & Bullish Acquisitions

Noah Lee 2025 Nov 15, 05:10

Crypto Sentiment Dips to Fearful Levels Amid Macroeconomic Uncertainty: An Analysis

Info

Spread

1.20

Spread (%)

0.6141 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

472053186560

Shares Outstanding

2409295102

Earnings Date (Next)

2001-06-13

Div Yield

2025-12-09

Ex-Dividend Date

2025-11-25

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0266

EPS

10.38

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 13, 16:00

Which broker is best for bitcoin trading: Cheapest Ways to Buy Bitcoin In 2026

Ghko B 2025 Nov 13, 16:00

Crypto day trading strategy: How to day trade crypto as a beginner?

Ghko B 2025 Nov 13, 16:00

Commodity trading strategy: WTI Oil faces potential decline, what’s next?

Trustpilot